Literature DB >> 9234040

Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.

S J Leischow1, S N Valente, A L Hill, P S Otte, M Aickin, T Holden, E Kligman, G Cook.   

Abstract

The effects of using several nicotine replacement treatments on self-reported withdrawal symptoms and side effects during 2-day periods of smoking cessation, with 5 days of ad lib smoking between cessation days, were evaluated. Participants (N = 18) experienced the following conditions: nicotine gum, 24-hr patch, 16-hr patch, 24-hr patch plus gum, double 24-hr patch, and no nicotine replacement. The present study found morning urge to smoke was greater during the 16-hr than during the 24-hr patch condition. Double-patch use resulted in significantly greater insomnia than the smoking baseline and 16-hr patch conditions. The no medication and gum alone conditions resulted in similar withdrawal symptoms, and both tended to result in greater reported withdrawal symptoms than the smoking baseline condition. There were no significant withdrawal symptom differences between the 24-hr, patch-gum, and double-patch conditions. The 24-hr and double-patch conditions were preferred by two thirds of the participants (6 each).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234040     DOI: 10.1037//1064-1297.5.1.54

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  12 in total

Review 1.  Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability.

Authors:  C T Sweeney; R V Fant; K O Fagerstrom; J F McGovern; J E Henningfield
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Effects of olfactory stimuli on urge reduction in smokers.

Authors:  M A Sayette; D J Parrott
Journal:  Exp Clin Psychopharmacol       Date:  1999-05       Impact factor: 3.157

3.  Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Authors:  Sarah E Evans; Melissa Blank; Cynthia Sams; Michael F Weaver; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

4.  Comparison of three nicotine treatments: initial reactions and preferences with guided use.

Authors:  Nina G Schneider; Scott Terrace; Margaret A Koury; Shilpan Patel; Behram Vaghaiwalla; Regina Pendergrass; Richard E Olmstead; Chris Cortner
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

5.  Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.

Authors:  Vincenzo Teneggi; Stephen T Tiffany; Lisa Squassante; Stefano Milleri; Luigi Ziviani; Alan Bye
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

6.  Preferences among four combination nicotine treatments.

Authors:  Nina G Schneider; Margaret A Koury; Chris Cortner; Richard E Olmstead; Neil Hartman; Leonard Kleinman; Andrew Kim; Craig Chaya; David Leaf
Journal:  Psychopharmacology (Berl)       Date:  2006-08-01       Impact factor: 4.530

7.  Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: a pilot study.

Authors:  Melissa A Miller; Anya Bershad; Andrea C King; Royce Lee; Harriet de Wit
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

Review 8.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 9.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

10.  Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program.

Authors:  Robert A Schnoll; Elisa Martinez; Kristina L Tatum; Marcella Glass; Albert Bernath; Daron Ferris; Patrick Reynolds
Journal:  Drug Alcohol Depend       Date:  2009-12-09       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.